Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

Clinical trial NCT05013099 · UNKNOWN

Trial details

NCT number: NCT05013099
Sponsor: ImaginAb, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Merkel Cell Carcinoma, Unspecified Renal Cell Carcinoma Non Small Cell Lung Cancer

Start date: 2021-12-09
Primary completion: 2025-07-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.